Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3405255 | International Journal of Mycobacteriology | 2014 | 6 Pages |
Abstract
A live, attenuated form of Mycobacterium bovis, bacillus Calmette–Guérin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Brittany J. Holmes, Richard W. LaRue, James H. Black III, Kim Dionne, Nicole M. Parrish, Michael T. Melia,